These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 39305006

  • 1. The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol.
    Topkan E, Kilic Durankus N, Senyurek S, Öztürk D, Besen AA, Mertsoylu H, Pehlivan B, Selek U.
    Int J Immunopathol Pharmacol; 2024; 38():3946320241284089. PubMed ID: 39305006
    [Abstract] [Full Text] [Related]

  • 2. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
    Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi Y, Pehlivan B, Selek U.
    J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
    [Abstract] [Full Text] [Related]

  • 3. Unraveling the Predictive Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) on Survival Outcomes in Patients with Grade 4 Adult-Type Diffuse Gliomas.
    Aydin AA, Yuceer RO.
    Curr Oncol; 2024 Aug 28; 31(9):5027-5039. PubMed ID: 39330000
    [Abstract] [Full Text] [Related]

  • 4. The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
    Topkan E, Selek U, Pehlivan B, Kucuk A, Ozturk D, Ozdemir BS, Besen AA, Mertsoylu H.
    Cancers (Basel); 2023 Sep 11; 15(18):. PubMed ID: 37760482
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O, Telli TA, Basoğlu T, Arikan R, Demircan NC, Ercelep O, Bozkurt S, Atasoy BM, Dane F, Yumuk PF.
    Clin Neurol Neurosurg; 2020 Sep 11; 196():105976. PubMed ID: 32531614
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
    Topkan E, Besen AA, Ozdemir Y, Kucuk A, Mertsoylu H, Pehlivan B, Selek U.
    Mediators Inflamm; 2020 Sep 11; 2020():4392189. PubMed ID: 32565725
    [Abstract] [Full Text] [Related]

  • 7. Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    Lopes M, Carvalho B, Vaz R, Linhares P.
    J Neurooncol; 2018 Jan 11; 136(1):173-180. PubMed ID: 29076002
    [Abstract] [Full Text] [Related]

  • 8. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
    Illic R, Somma T, Savic D, Frio F, Milicevic M, Solari D, Nikitovic M, Lavrnic S, Raicevic S, Milosevic S, Cavallo LM, Cappabianca P, Grujicic D.
    World Neurosurg; 2017 Aug 11; 104():581-588. PubMed ID: 28522381
    [Abstract] [Full Text] [Related]

  • 9. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
    Wang Y, Zhang J, Li W, Jiang T, Qi S, Chen Z, Kang J, Huo L, Wang Y, Zhuge Q, Gao G, Wu Y, Feng H, Zhao G, Yang X, Zhao H, Wang Y, Yang H, Kang D, Su J, Li L, Jiang C, Li G, Qiu Y, Wang W, Wang H, Xu Z, Zhang L, Wang R.
    Future Oncol; 2021 Nov 11; 17(33):4571-4582. PubMed ID: 34519220
    [Abstract] [Full Text] [Related]

  • 10. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A, Friger M, Geffen DB, Kaisman-Elbaz T, Lavrenkov K.
    Oncology; 2019 Nov 11; 97(5):255-263. PubMed ID: 31288238
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme.
    Yılmaz H, Niğdelioğlu B, Oktay E, Meydan N.
    J Clin Neurosci; 2021 Apr 11; 86():260-266. PubMed ID: 33775339
    [Abstract] [Full Text] [Related]

  • 12. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    Garrett C, Becker TM, Lynch D, Po J, Xuan W, Scott KF, de Souza P.
    PLoS One; 2021 Apr 11; 16(6):e0252614. PubMed ID: 34138894
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
    Kefayat A, Amouheidari A, Ghahremani F, Alirezaei Z.
    Cancer Med; 2021 Aug 11; 10(15):5154-5162. PubMed ID: 34250760
    [Abstract] [Full Text] [Related]

  • 14. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme.
    Mermut O, Inanc B.
    Turk Neurosurg; 2020 Aug 11; 30(5):658-665. PubMed ID: 32530473
    [Abstract] [Full Text] [Related]

  • 15. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime.
    Teo M, Martin S, Owusu-Agyemang K, Nowicki S, Clark B, Mackinnon M, Stewart W, Paul J, St George J.
    Br J Neurosurg; 2014 Jun 11; 28(3):351-5. PubMed ID: 24111708
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide.
    Topkan E, Kucuk A, Selek U.
    J Immunol Res; 2022 Jun 11; 2022():1346094. PubMed ID: 36479136
    [Abstract] [Full Text] [Related]

  • 17. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y, Li X, Chen H, Huo H, Liu Z, Tian F, Chai E.
    World Neurosurg; 2019 Aug 11; 128():e427-e433. PubMed ID: 31042598
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC.
    Radiat Oncol; 2015 Oct 31; 10():222. PubMed ID: 26520780
    [Abstract] [Full Text] [Related]

  • 19. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
    Jiang H, Zeng W, Ren X, Cui Y, Li M, Yang K, Elbaroody M, Lin S.
    J Neurooncol; 2019 Aug 31; 144(1):127-135. PubMed ID: 31175579
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.